Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle E McClements

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
JAMA Ophthalmology|January 28, 2021
Analysis of Pathogenic Variants Correctable With CRISPR Base Editing Among Patients With Recessive Inherited Retinal DegenerationLewis E Fry, Michelle E McClements, Robert E MacLaren
International Journal of Molecular Sciences|October 14, 2022
Minicircle Delivery to the Neural Retina as a Gene Therapy ApproachFederica Staurenghi, Michelle E McClements, Ahmed Salman, et al.
Current Gene Therapy|October 8, 2021
CRISPR Systems Suitable for Single AAV Vector DeliveryMarta Stevanovic, Elena Piotter, Michelle E McClements, et al.
Journal of Genetic Syndromes & Gene Therapy|February 28, 2017
A fragmented adeno-associated viral dual vector strategy for treatment of diseases caused by mutations in large genes leads to expression of hybrid transcriptsMichelle E McClements, Peter Charbel Issa, Véronique Blouin, et al.
Cells|February 11, 2023
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal DiseasesSilja Hansen, Michelle E McClements, Thomas J Corydon, et al.
Frontiers in Neuroscience|December 2, 2020
Optogenetic Gene Therapy for the Degenerate Retina: Recent AdvancesMichelle E McClements, Federica Staurenghi, Robert E MacLaren, et al.
Experimental Eye Research|May 8, 2021
Deep phenotyping of the Cdhr1<sup>-/-</sup> mouse validates its use in pre-clinical studies for human CDHR1-associated retinal degenerationImran H Yusuf, Michelle E McClements, Robert E MacLaren, et al.
Genes|April 30, 2021
Accurate Quantification of AAV Vector Genomes by Quantitative PCRCristina Martinez-Fernandez de la Camara, Michelle E McClements, Robert E MacLaren
Frontiers in Molecular Neuroscience|June 9, 2023
Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?Julia-Sophia Bellingrath, Michelle E McClements, M Dominik Fischer, et al.
Translational Vision Science & Technology|July 30, 2020
Assessment of AAV Dual Vector Safety in the<i>Abca4</i><sup>-/-</sup> Mouse Model of Stargardt DiseaseMichelle E McClements, Alun R Barnard, Peter Charbel Issa, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
JAMA Ophthalmology|January 28, 2021
Analysis of Pathogenic Variants Correctable With CRISPR Base Editing Among Patients With Recessive Inherited Retinal DegenerationLewis E Fry, Michelle E McClements, Robert E MacLaren
International Journal of Molecular Sciences|October 14, 2022
Minicircle Delivery to the Neural Retina as a Gene Therapy ApproachFederica Staurenghi, Michelle E McClements, Ahmed Salman, et al.
Current Gene Therapy|October 8, 2021
CRISPR Systems Suitable for Single AAV Vector DeliveryMarta Stevanovic, Elena Piotter, Michelle E McClements, et al.
Journal of Genetic Syndromes & Gene Therapy|February 28, 2017
A fragmented adeno-associated viral dual vector strategy for treatment of diseases caused by mutations in large genes leads to expression of hybrid transcriptsMichelle E McClements, Peter Charbel Issa, Véronique Blouin, et al.
Cells|February 11, 2023
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal DiseasesSilja Hansen, Michelle E McClements, Thomas J Corydon, et al.
Frontiers in Neuroscience|December 2, 2020
Optogenetic Gene Therapy for the Degenerate Retina: Recent AdvancesMichelle E McClements, Federica Staurenghi, Robert E MacLaren, et al.
Experimental Eye Research|May 8, 2021
Deep phenotyping of the Cdhr1<sup>-/-</sup> mouse validates its use in pre-clinical studies for human CDHR1-associated retinal degenerationImran H Yusuf, Michelle E McClements, Robert E MacLaren, et al.
Genes|April 30, 2021
Accurate Quantification of AAV Vector Genomes by Quantitative PCRCristina Martinez-Fernandez de la Camara, Michelle E McClements, Robert E MacLaren
Frontiers in Molecular Neuroscience|June 9, 2023
Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?Julia-Sophia Bellingrath, Michelle E McClements, M Dominik Fischer, et al.
Translational Vision Science & Technology|July 30, 2020
Assessment of AAV Dual Vector Safety in the<i>Abca4</i><sup>-/-</sup> Mouse Model of Stargardt DiseaseMichelle E McClements, Alun R Barnard, Peter Charbel Issa, et al.
Pageof 7